Journal · Molecular neuroscience · Updated 21 November 2026
NeuroMolecular Medicine
Read NeuroMolecular Medicine articles on DeepDyve. No university library needed.
NeuroMolecular Medicine has published since 2002 and covers the molecular and cellular basis of nervous system disorders, from brain aging and myelin damage to childhood brain tumors and inflammation in the brain. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
NeuroMolecular Medicine at a glance
- Full title
- NeuroMolecular Medicine
- Abbreviation (NLM)
- Neuromolecular Med
- Publisher
- Springer Nature
- Print ISSN
- 1535-1084
- Online ISSN (eISSN)
- 1559-1174
- First published
- 2002
- Subjects
- Molecular Biology, Neurology
- Access model
- Hybrid (25% free to read in 2026)
Ways to access NeuroMolecular Medicine
25% of the articles NeuroMolecular Medicine published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 25% of NeuroMolecular Medicine articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to NeuroMolecular Medicine. Check its journal list and whether it offers remote access.
- DeepDyve. Read NeuroMolecular Medicine articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
NeuroMolecular Medicine’s 2025 Journal Impact Factor is 3.8, and its 5-year Impact Factor is 3.7.
3.8
Journal Impact Factor (2025)
3.7
5-year Impact Factor (2025)
2 days
Median time to first decision
Source: journal metrics on the NeuroMolecular Medicine homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent NeuroMolecular Medicine research worth reading
Published March to June 2026. Summaries describe what the authors report.
-
SIRT1 Activators as Geroprotective Agents in Brain Aging: Mechanisms and Therapeutic Potential
Alameen and colleagues review evidence that SIRT1 activators may protect the aging brain by reducing neuronal senescence, enhancing autophagy and dampening inflammation, and argue that SIRT1 is a promising target for age-associated brain disorders that needs more translational study in humans.
Alameen et al. · NeuroMolecular Medicine, published online April 4, 2026 · DOI 10.1007/s12017-026-08923-y
-
Revisiting the Peripheral Nerve Injury and Regeneration
Liu and colleagues review peripheral nerve injury repair from three angles: boosting intrinsic axonal growth, improving the repair environment shaped by Schwann cells and macrophages, and ensuring correct reconnection to target tissue, along with surgical, drug-based and newer treatments.
Liu et al. · NeuroMolecular Medicine, published online April 28, 2026 · DOI 10.1007/s12017-026-08914-z
-
Enhanced Neurophysiological Benefits of Magnesium-Acetyl-Taurate Over Magnesium-L-Threonate: A Comparative pre-clinical Study on Bioavailability, Synaptic Plasticity and Cognitive Functions
In a preclinical study in adult Wistar rats, Kumar and colleagues report that magnesium-acetyl-taurate gave more notable improvements in cognitive functions, neuromuscular strength and motor coordination than magnesium-L-threonate.
Kumar et al. · NeuroMolecular Medicine, published online May 5, 2026 · DOI 10.1007/s12017-026-08929-6
-
Molecular and Pathophysiological Mechanisms Underlying Chronic Subdural Hematoma Recurrence: A Comprehensive Review
In a narrative review, Bhatt and colleagues describe recurrent chronic subdural hematoma, which occurs in up to 30% of cases after treatment, as reflecting a persistent pro-inflammatory and pro-angiogenic environment in the neomembrane rather than incomplete evacuation alone.
Bhatt et al. · NeuroMolecular Medicine, published online June 10, 2026 · DOI 10.1007/s12017-026-08934-9
-
Miro1 in Parkinson’s Disease: A Key Regulator of Mitochondrial Homeostasis and Neurodegeneration
Singh and colleagues review the role of Miro1, a regulator of mitochondrial motility, in Parkinson’s disease, describing how its dysregulation or mutation disrupts mitochondrial transport, mitophagy and calcium homeostasis in dopaminergic neurons, and the prospects for Miro1-targeted therapies.
Singh et al. · NeuroMolecular Medicine, published online March 7, 2026 · DOI 10.1007/s12017-026-08917-w
Related journals
Questions about NeuroMolecular Medicine
How can I read NeuroMolecular Medicine articles without a subscription?
25% of NeuroMolecular Medicine articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read NeuroMolecular Medicine articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for NeuroMolecular Medicine?
NeuroMolecular Medicine’s NLM (PubMed) abbreviation is Neuromolecular Med.
What is the ISSN of NeuroMolecular Medicine?
The print ISSN is 1535-1084 and the online ISSN is 1559-1174.
What is the impact factor of NeuroMolecular Medicine?
NeuroMolecular Medicine’s Journal Impact Factor is 3.8 (2025), and its 5-year Impact Factor is 3.7, according to Springer Nature’s published metrics.
Is NeuroMolecular Medicine open access?
NeuroMolecular Medicine is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 19, 2026, 13 of 52 NeuroMolecular Medicine articles (25%) carry a Creative Commons license, per Crossref.
NeuroMolecular Medicine articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading NeuroMolecular Medicine today
One month free, then less than $2 a day. NeuroMolecular Medicine, plus millions of articles from thousands of journals.





